Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 46,666 shares at $16.86 ($787K) on 2021-06-10, disclosed to the SEC on 2021-06-14.
Seasonal sale ($787k) by Director — this insider has traded BCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.86 | 23,333 | $393K | 50.0% |
| 2 | $16.86 | 23,333 | $393K | 50.0% |
| Total | $16.86 avg | 46,666 | $787K | 100% |
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |